bazedoxifene has been researched along with Animal Mammary Carcinoma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Atkins, KA; Blair, IA; Bottalico, L; Mesaros, C; Santen, RJ; Wang, J; Yue, W | 1 |
| Santen, RJ; Song, Y; Wang, JP; Yue, W | 1 |
2 other study(ies) available for bazedoxifene and Animal Mammary Carcinoma
| Article | Year |
|---|---|
Effect of a tissue selective estrogen complex on breast cancer: Role of unique properties of conjugated equine estrogen.
Topics: Animals; Apoptosis; Carcinogens; Cell Proliferation; Drug Therapy, Combination; Estrogen Replacement Therapy; Estrogens; Estrogens, Conjugated (USP); Female; Indoles; Mammary Neoplasms, Animal; Methylnitrosourea; Progestins; Rats; Rats, Inbred ACI; Rats, Sprague-Dawley; Selective Estrogen Receptor Modulators | 2018 |
Effects of the conjugated equine estrogen/bazedoxifene tissue-selective estrogen complex (TSEC) on mammary gland and breast cancer in mice.
Topics: Animals; Cell Line, Tumor; Cell Proliferation; Estradiol; Estrogens; Estrogens, Conjugated (USP); Female; Gene Expression Regulation; Horses; Humans; Indoles; Mammary Neoplasms, Animal; Mice; Mice, Inbred C57BL; Mice, Nude; Neoplasm Transplantation; Selective Estrogen Receptor Modulators | 2012 |